Several studies have shown that serum hs-CRP and IL-6 levels can be used as indicators to assess the degree of coronary heart disease (22) and may also be used to reflect the activity of plaque in patients with coronary heart disease; therefore, these biomarkers are of great significance for the clinical diagnosis and risk assessment of patients with ACS (24). Here, IL6 is linked to coronary artery disorder.